Department of Microbiology, Busan, Republic of Korea.
J Ethnopharmacol. 2012 Aug 1;142(3):819-28. doi: 10.1016/j.jep.2012.06.006. Epub 2012 Jun 15.
Acanthopanax senticosus (Rupr. & Maxim.) Harms (AS) has been used as a traditional medicine for the treatment of hypertension, rheumatism, ischemic heart disease, diabetes, and hepatitis in East Asia. This herb has been reported to possess anti-cancer, anti-diabetes, and anti-inflammatory properties.
To examine the anti-inflammatory activity of AS extract (ASE) and its mechanism of action in Porphyromonas gingivalis lipopolysaccharide (P. gingivalis LPS)-stimulated macrophages.
P. gingivalis LPS was used to induce an inflammatory response in the murine macrophage cell line RAW 264.7. Pro-inflammatory cytokines were measured by using an enzyme-linked immunosorbent assay. We used western blot assays and real-time quantitative polymerase chain reaction to detect protein and mRNA expression, respectively. Luciferase assays were performed to determine the transactivity of transcription factors. Nuclear translocation of nuclear factor (NF)-κB was assessed by confocal microscopy.
ASE significantly induced the expression and activity of heme oxygenase-1 (HO-1), which is known to produce an anti-inflammatory effect, in RAW 264.7 cells, through NF-E2-related factor 2 (Nrf-2), Janus kinase, and extracellular signal-regulated kinase activation. ASE also effectively suppressed the production of pro-inflammatory cytokines, tumor necrosis factor α, interleukin (IL)-1β, and IL-6, and decreased the nuclear translocation and transactivity of activator protein-1 (AP-1) and NF-κB by inhibiting the phosphorylation of IκB-α in P. gingivalis LPS-stimulated macrophage cells. Furthermore, ASE inhibits signal transducer and activator of transcription (STAT)1 phosphorylation while it activates STAT3 phosphorylation in P. gingivalis LPS-stimulated RAW 264.7 cells.
Our study suggests that ASE produces anti-inflammatory effects on P. gingivalis LPS-stimulated macrophages through a reduction in AP-1 and NF-κB activity, modulation of STAT1 and STAT3 phosphorylation, and upregulation of HO-1 expression through the activation of mitogen-activated protein kinase and Nrf-2 signaling pathways. Therefore, ASE could be a candidate for the prevention and treatment of periodontal diseases that involve excessive inflammation.
刺五加(AS)已被用作传统药物,用于治疗东亚的高血压、风湿、缺血性心脏病、糖尿病和肝炎。这种草药被报道具有抗癌、抗糖尿病和抗炎作用。
研究刺五加提取物(ASE)的抗炎活性及其在牙龈卟啉单胞菌脂多糖(P. gingivalis LPS)刺激的巨噬细胞中的作用机制。
使用 P. gingivalis LPS 诱导小鼠巨噬细胞系 RAW 264.7 产生炎症反应。通过酶联免疫吸附试验测量促炎细胞因子。我们使用 Western blot 分析和实时定量聚合酶链反应分别检测蛋白质和 mRNA 的表达。荧光素酶分析用于测定转录因子的转录活性。通过共聚焦显微镜评估核因子(NF)-κB 的核转位。
ASE 通过 NF-E2 相关因子 2(Nrf-2)、Janus 激酶和细胞外信号调节激酶的激活,显著诱导 RAW 264.7 细胞中血红素加氧酶-1(HO-1)的表达和活性,HO-1 已知具有抗炎作用。ASE 还通过抑制 IκB-α的磷酸化,有效抑制 P. gingivalis LPS 刺激的巨噬细胞中促炎细胞因子肿瘤坏死因子-α、白细胞介素(IL)-1β和 IL-6 的产生,并减少 AP-1 和 NF-κB 的核转位和转录活性。此外,ASE 抑制信号转导和转录激活因子(STAT)1 的磷酸化,同时在 P. gingivalis LPS 刺激的 RAW 264.7 细胞中激活 STAT3 的磷酸化。
我们的研究表明,ASE 通过降低 AP-1 和 NF-κB 活性、调节 STAT1 和 STAT3 磷酸化以及通过激活丝裂原活化蛋白激酶和 Nrf-2 信号通路上调 HO-1 表达,对 P. gingivalis LPS 刺激的巨噬细胞产生抗炎作用。因此,ASE 可能成为预防和治疗涉及过度炎症的牙周病的候选药物。